MS

Manjit Singh Anand

Director Director DIN 02233793
DIN 02233793 First appointment Jul 2008 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jul 2008
Shareholding value Locked Premium profile

About Manjit Singh Anand

Manjit Singh Anand has 18 years in corporate governance. Formerly with 1 company, such as Redan Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 02233793
Primary Designation Director
First Appointment 15 Jul 2008
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Director 15 Jul 2008 2008 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Redan Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Manjit Singh Anand

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manjit Singh Anand

Manjit Singh Anand has 18 years in corporate governance. Formerly with 1 company, such as Redan Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Manjit Singh Anand is associated with 0 companies as a director.

Manjit Singh Anand has expertise in General Business.

Manjit Singh Anand has 18 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available